HETLIOZ LQ FDA approval date
The FDA approved HETLIOZ LQ on 1 Dec 2020.
- FDA approval date
- 1 Dec 2020
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as TASIMELTEON
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2020-12-01Day | HETLIOZ LQ | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA214517", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["HETLIOZ LQ"], "active_ingredients": ["TASIMELTEON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20201201", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |